MétaCan
Menu
← Back to cohort
Record W4307858518 · doi:10.1210/jendso/bvac150.1595

ODP495 Medullary Thyroid Cancer Outcome in a Tertiary Care Centre in Atlantic Canada

2022· article· en· W4307858518 on OpenAlexaboutno aff
Kye Rajaraman, Emily Devereaux, Murali Rajaraman, Syed Ali Imran

Bibliographic record

VenueJournal of the Endocrine Society · 2022
Typearticle
Languageen
FieldMedicine
TopicThyroid Cancer Diagnosis and Treatment
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineThyroid cancerMedullary thyroid cancerThyroid carcinomaInternal medicineProspective cohort studyThyroidIncidence (geometry)CohortAJCC staging systemCancerOncologyPediatrics

Abstract

fetched live from OpenAlex

Abstract Background Medullary thyroid carcinoma (MTC) constitutes around 1-2% of all thyroid cancer with a paucity of published data. Distinctively, MTC has a strong genetic component with oncogene mutations. For AJCC stages I, II, III, and IV, 5-year overall survival (OS) rates are 100, 90, 86.5 and 55.5%. The aims of this study are to report outcomes of the MTC patient cohort managed at a single tertiary cancer centre and specifically that of the subset of patients who have a biochemically incomplete response to primary surgical management. Objectives Explore the incidence and outcome of MTC including demographics, stage, genetic mutation status, dynamic risk stratification (DRS), and OS rate. Compare the outcome of MTC patients found to have low detectable post-op calcitonin (POC) levels (10-200 pg/ml=Grp B)) with those who have undetectable (< 10 pg/ml=Grp A) and significantly high-level POC levels (>200 pg/ml=Grp C). Methods Patients with MTC were identified from the Interdisciplinary Thyroid Oncology Clinic (ITOC) prospective database. Data was extracted and completed with a chart review. Results 35 cases with MTC were identified from 1570 cases. 21/35 were males. The diagnosis was made between 1988 and 2019 with a median age at diagnosis of 50 years (range=15 to 77) and a median follow-up of 8 years. Distribution (and 5-year OS, p=0.515) across Stages I, II, III, IV were 23% (100%), 14% (100%), 17% (100%) and 32% (90%) respectively with 14% unknown. 10 (29%) tested positive for RET gene mutations. Post-operative DRS response to initial treatment for 29 cases found 48%, 35%, and 17% were classified into excellent (E=undetectable calcitonin), biochemical incomplete (B=only detectable calcitonin), or structural incomplete (S=structural disease present) respectively. The 29 cases with available POC and DRS were divided into Groups A, B, and C based on POC levels as above. The final status at last follow up for Grp A was 13/14 (93%) with E and 1 (7%) with S, for Grp B 6/9 (67%) with B, 3/9 (33%) with S, and for Grp C 6/6 (100%) with S. The DRS for Grp A, B and C was 100% E, 89% B and 11% S, and 33% B and 67% S. The 5-year OS for Grp A, B, C was 100%, 89%, 100% (p=0.223) respectively. Conclusion This cohort of MTC cases failed to show significant differences in OS by stage and POC levels but did exhibit a higher rate of genetic mutations (29%) than those from other regions of Canada. Additionally, a biochemically incomplete response with a POC level above 200 pg/ml was highly suggestive of progressive structural disease as final outcome. This study will provide the template for a national survey of MTC in Canada facilitating analysis of a larger dataset. Presentation: No date and time listed

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.054
Threshold uncertainty score0.138

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.003
Science and technology studies0.0020.001
Scholarly communication0.0010.000
Open science0.0010.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.263
Teacher spread0.255 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueJournal of the Endocrine Society→Same topicThyroid Cancer Diagnosis and Treatment→French-language works237,207→